Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the ...

Researchers have produced a review of chromatography media and purification processes for handling complex and super-large ...

CD Bioparticles recently announced the availability of its new line of Exosome Extraction Kits. NEW YORK, NY, UNITED STATES, February 21, 2025 ...

Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...

Fascinating new research shows mollusk blood proteins have strong antimicrobial properties, especially when combined with ...

This valuable work presents how PRDM16 plays a critical role during colloid plexus development, through regulating BMP signaling. Solid evidence supports the context-dependent gene regulatory ...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide ...

No.: 1001891922); PBS was purchased from Servicebio corporation (Cat. No.: G4200-500ML); HiTrap Protein A HP antibody purification column was purchased from Cytiva (Cat. No.:17-0402-01) PBST (0.1% ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Q4 2024 Earnings Call Transcript February 20, 2025 Repligen Corporation beats earnings expectations. Reported EPS is $0.44, ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong Buy.

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...